Mavroudis Georgios, Simren Magnus, Jonefjäll Börje, Öhman Lena, Strid Hans
Sahlgrenska University Hospital, Department of Internal Medicine, Blå Stråket 5, Gothenburg 41346, Sweden.
Sahlgrenska University Hospital, Department of Internal Medicine, Gothenburg, Sweden.
Therap Adv Gastroenterol. 2019 Feb 19;12:1756284819827689. doi: 10.1177/1756284819827689. eCollection 2019.
Whether patients with inactive ulcerative colitis (UC) have symptoms compatible with functional bowel disorders (FBDs) other than irritable bowel syndrome (IBS) is unclear. Our aim was to investigate the prevalence and burden of these symptoms and determine impact on the UC course.
We used Mayo score, sigmoidoscopy and calprotectin (f-cal) to define remission in 293 UC patients. Presence of symptoms compatible with FBD, severity of gastrointestinal, extraintestinal and psychological symptoms, stress levels and quality of life (QoL) were measured with validated questionnaires. At 1 year later, remission was determined by modified Mayo score and f-cal in 171 of these patients. They completed the same questionnaires again.
A total of 18% of remission patients had symptoms compatible with FBD other than IBS, and 45% subthreshold symptoms compatible with FBD. The total burden of gastrointestinal symptoms in patients with symptoms compatible with FBD was higher than in patients without FBD ( < 0.001), which had negative impact on QoL ( = 0.02). These symptoms were not correlated with psychological distress, systemic immune activity or subclinical colonic inflammation and were not a risk factor for UC relapse during follow up.
Symptoms compatible with FBD other than IBS are common during UC remission influencing patients' QoL but not the UC course.
非活动期溃疡性结肠炎(UC)患者是否存在除肠易激综合征(IBS)之外与功能性肠病(FBD)相符的症状尚不清楚。我们的目的是调查这些症状的患病率和负担,并确定其对UC病程的影响。
我们使用梅奥评分、乙状结肠镜检查和钙卫蛋白(f-cal)来定义293例UC患者的缓解情况。使用经过验证的问卷测量与FBD相符的症状的存在情况、胃肠道、肠外和心理症状的严重程度、压力水平和生活质量(QoL)。1年后,通过改良梅奥评分和f-cal对其中171例患者进行缓解情况的判定。他们再次完成相同的问卷。
共有18%的缓解期患者存在除IBS之外与FBD相符的症状,45%存在与FBD相符的阈下症状。有与FBD相符症状的患者的胃肠道症状总负担高于无FBD的患者(<0.001),这对生活质量有负面影响(=0.02)。这些症状与心理困扰、全身免疫活动或亚临床结肠炎症无关,且不是随访期间UC复发的危险因素。
除IBS之外与FBD相符的症状在UC缓解期很常见,会影响患者的生活质量,但不影响UC病程。